A Phase1 Clinical Trial to Evaluate the Safety, Mucosal and Innate Immunity of Adenovirus Type 26 HIV-1 Vaccine in Healthy, HIV-1 Uninfected Adults

被引：0
|
作者：
Baden, L. R. [1 ]
Liu, J. [2 ]
Li, H. [2 ]
Walsh, S. [1 ]
Johnson, J. [1 ]
Milner, D. [1 ]
Seaman, M. [2 ]
Krause, K. [1 ]
Swan, E. [3 ]
Tucker, R. [1 ]
Weijtens, M.
Pau, M.
Dolin, R. [2 ]
Barouch, D. H. [2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[3] NIAID, DAIDS, NIH, Bethesda, MD 20892 USA
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2011年 / 27卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：A124 / A124
页数：1
相关论文
共 50 条
  • [1] CTL RESPONSES IN HIV-1 UNINFECTED VOLUNTEERS PARTICIPATING IN PHASE-1 HIV-1 VACCINE TRIALS
    MCELRATH, MJ
    COREY, L
    RABIN, M
    HOFFMAN, M
    KLUCKING, S
    GREENBERG, PD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 82 - 82
  • [2] Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C gag Vaccine in Healthy HIV-1-Uninfected Adults
    Wecker, M.
    Gilbert, P.
    Russell, N.
    Hural, J.
    Allen, M.
    Pensiero, M.
    Chulay, J.
    Chiu, Ya-Lin
    Karim, S. S. Abdool
    Burke, D. S.
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (10) : 1651 - 1660
  • [3] A Recombinant Vesicular Stomatitis Virus (rVSV) HIV-1 Gag Vaccine Is Safe and Immunogenic in Healthy, HIV-1 Uninfected Phase I Trial Participants
    Fuchs, J. D.
    Frank, I.
    Elizaga, M.
    Kochar, N.
    Allen, M.
    Frahm, N.
    Carter, D. K.
    Li, S.
    Edupuganti, S.
    Kalams, S.
    Sheets, R.
    Pensiero, M.
    Latham, T.
    Egan, M.
    Clarke, D.
    Eldridge, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A74 - A75
  • [4] First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
    Baden, L. R.
    Dolin, R.
    O'Brien, K. L.
    Abbink, P.
    La Porte, A.
    Seaman, M. S.
    Choi, E.
    Tucker, R.
    Weitjens, M.
    Pau, M. G.
    Goudsmit, J.
    Barouch, D. H.
    RETROVIROLOGY, 2009, 6
  • [5] Assessment of mucosal immunity to HIV-1
    Jespers, Vicky
    Harandi, Ali M.
    Hinkula, Jorma
    Medaglini, Donata
    Le Grand, Roger
    Stahl-Hennig, Christiane
    Bogers, Willy
    El Habib, Raphaelle
    Wegmann, Frank
    Fraser, Carol
    Cranage, Martin
    Shattock, Robin J.
    Spetz, Anna-Lena
    EXPERT REVIEW OF VACCINES, 2010, 9 (04) : 381 - 394
  • [6] Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
    Buchbinder, Susan P.
    Grunenberg, Nicole A.
    Sanchez, Brittany J.
    Seaton, Kelly E.
    Ferrari, Guido
    Moody, M. Anthony
    Frahm, Nicole
    Montefiori, David C.
    Hay, Christine M.
    Goepfert, Paul A.
    Baden, Lindsey R.
    Robinson, Harriet L.
    Yu, Xuesong
    Gilbert, Peter B.
    McElrath, M. Juliana
    Huang, Yunda
    Tomaras, Georgia D.
    PLOS ONE, 2017, 12 (07):
  • [7] Critical issues in mucosal immunity for HIV-1 vaccine development
    Haynes, Barton F.
    Shattock, Robin J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (01) : 3 - 9
  • [8] A controlled, phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA
    Wong-Staal, F
    Poeschla, EM
    Looney, DJ
    HUMAN GENE THERAPY, 1998, 9 (16) : 2407 - 2425
  • [9] Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults
    Kalams, Spyros A.
    Parker, Scott
    Jin, Xia
    Elizaga, Marnie
    Metch, Barbara
    Wang, Maggie
    Hural, John
    Lubeck, Michael
    Eldridge, John
    Cardinali, Massimo
    Blattner, William A.
    Sobieszczyk, Magda
    Suriyanon, Vinai
    Kalichman, Artur
    Weiner, David B.
    Baden, Lindsey R.
    PLOS ONE, 2012, 7 (01):
  • [10] Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
    Kopycinski, Jakub
    Hayes, Peter
    Ashraf, Ambreen
    Cheeseman, Hannah
    Lala, Francesco
    Czyzewska-Khan, Justyna
    Spentzou, Aggeliki
    Gill, Dilbinder K.
    Keefer, Michael C.
    Excler, Jean-Louis
    Fast, Patricia
    Cox, Josephine
    Gilmour, Jill
    PLOS ONE, 2014, 9 (03):
12345